Akari Therapeutics Plc Annual Depreciation, Depletion and Amortization in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Akari Therapeutics Plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2014 to 2023.
  • Akari Therapeutics Plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $13K, a 1200% increase year-over-year.
  • Akari Therapeutics Plc annual Depreciation, Depletion and Amortization for 2023 was $4K, unchanged from 2022.
  • Akari Therapeutics Plc annual Depreciation, Depletion and Amortization for 2022 was $4K, a 3.05% decline from 2021.
  • Akari Therapeutics Plc annual Depreciation, Depletion and Amortization for 2021 was $4.13K, a 53.7% decline from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $4K -$126 -3.05% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $4.13K -$4.78K -53.7% Jan 1, 2021 Dec 31, 2021 20-F 2023-05-01
2020 $8.91K -$10.3K -53.6% Jan 1, 2020 Dec 31, 2020 20-F 2023-05-01
2019 $19.2K -$16.6K -46.4% Jan 1, 2019 Dec 31, 2019 20-F 2022-05-16
2018 $35.8K -$6.55K -15.5% Jan 1, 2018 Dec 31, 2018 20-F 2021-04-21
2017 $42.4K +$2.46K +6.15% Jan 1, 2017 Dec 31, 2017 20-F 2020-03-31
2016 $39.9K +$29.8K +293% Jan 1, 2016 Dec 31, 2016 20-F 2019-04-23
2015 $10.2K +$5.22K +106% Jan 1, 2015 Dec 31, 2015 20-F 2018-07-18
2014 $4.94K Jan 1, 2014 Dec 31, 2014 20-F 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.